Výsledky vyhledávání - "Steve Raskin"

Quantitative CT Assessment of Gynecomastia in the General Population and in Dialysis, Cirrhotic, and Obese Patients

Autor: Miri Sklair, Alon Grossman, Nayroz Kanana, Shelly Soffer, Marianne M. Amitai, Jana Pikovsky, Lior Heller, Eli Konen, Eyal Klang, Steve Raskin, Edith M. Marom

Publikováno v: Academic Radiology. 25:626-635

Rationale and Objectives Gynecomastia is the benign enlargement of the male breast because of proliferation of the glandular component. To date, there is no radiological definition of gynecomastia and no quantitative evaluation of breast glandular ti

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::989c7a40ffdc7e8abfe6d988ba164455
https://doi.org/10.1016/j.acra.2017.11.008

Zobrazit plný text záznamu

Pitfalls in diagnosing colon cancer on abdominal CT

Autor: M. Eifer, V. Belsky, Eyal Klang, Uri Kopylov, Eli Konen, Michal Amitai, Steve Raskin

Publikováno v: Clinical radiology. 72(10)

To assess the frequency of undetected colon cancer on conventional abdominal CT and to evaluate the imaging features that are characteristic of those cancers.The present study included consecutive patients diagnosed with colorectal cancer at colonosc

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::fcf54d1cca19e95b16f8f2dec9389c59
https://pubmed.ncbi.nlm.nih.gov/28687169

Zobrazit plný text záznamu

Torsed and Nontorsed Inguinal Undescended Testis: Comparison of Computed Tomography Findings

Autor: Marianne M. Amitai, Michalle Soudack, Zehava Heiman, Yeruham Kleinbaum, Nadin Kanaan, Eyal Klang, Steve Raskin

Publikováno v: Journal of computer assisted tomography. 41(4)

OBJECTIVE The aim of this study was to compare the computed tomography imaging features of a torsed inguinal testis with nontorsed inguinal testes. METHODS Computed tomography scans of patients with undescended testes were retrospectively collected (

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f037993c8c05bd3a7bc2ff24fde8fe81
https://pubmed.ncbi.nlm.nih.gov/28240634

Zobrazit plný text záznamu

Abstract B30: A phase 1 open label, dose-escalation trial evaluating the safety and tolerability of EF-022, macrophage activator, in subjects with advanced solid malignancies

Autor: Michal Shahar, Talia Golan, Uri Yogev, Aliza Ackerstein, Steve Raskin, Raanan Berger, Alexander M. Lesokhin, David Sidransky, Hana Gadassi, Mark L. Levitt

Publikováno v: Molecular Cancer Therapeutics. 14:B30-B30

Scientific background: Activated macrophages, present in excess during natural inflammatory responses, bear the potential to kill and eradicate cancer cells. Efranat has developed cancer immunotherapy based on macrophage activation using a plasma pro

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::6e903cd5c54793e5663d1aa93021c722
https://doi.org/10.1158/1535-7163.targ-15-b30

Zobrazit plný text záznamu

Target versus non-target lesions in determining disease progression: analysis of 545 patients

Autor: Eyal Klang, Michal Amitai, Steve Raskin

Publikováno v: Cancer Imaging

Aim RECIST and other methodologies emphasise tracking the diameters of target lesions (TLs) for the determination of progressive disease (PD) in randomised clinical trials. However, RECIST 1.1 also allows for the use of non TL lesions (NTL) to determ

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5377c2320848329f8e037b78409f4147
http://europepmc.org/articles/PMC4601547

Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání